Literature DB >> 3421150

Cardiovascular risk factors in the Northern Sweden MONICA Study.

F Huhtasaari1, K Asplund, P O Wester.   

Abstract

In the WHO MONICA Study, determinants and trends in cardiovascular disease are monitored during a 10-year period in 40 centers in 27 countries. The Northern Sweden MONICA Center is located furthest to the north of all participating centers. In this report, baseline data on cardiovascular risk factors are presented. In the first population screening, 1,625 of 2,000 (81%) invited individuals participated. Diastolic blood pressure greater than or equal to 90 mmHg was recorded in 19% and 9% were on drug treatment for hypertension. Median cholesterol level was 6.10 mmol/l and the frequency of hypercholesterolemia was high. A body mass index of greater than or equal to 30, indicating severe obesity, was observed in 9%, a lower proportion than in most other European populations. Among men, the total proportion of tobacco consumers was 49%, including 22% snuffers. Of the women, 31% were tobacco consumers, very few being snuffers. Women had, in general, a more favorable cardiovascular risk factor profile up to the age of 45. Thereafter, the two genders were similar. By international comparisons, the population in northern Sweden is characterized by high serum cholesterol levels, intermediate blood pressure levels, a relatively low prevalence of severe obesity and a high consumption of smokeless tobacco.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421150     DOI: 10.1111/j.0954-6820.1988.tb16746.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

1.  Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.

Authors:  J H Jansson; B Johansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Shifting the distribution of risk: results of a community intervention in a Swedish programme for the prevention of cardiovascular disease.

Authors:  L Weinehall; G Westman; G Hellsten; K Boman; G Hallmans; T A Pearson; S Wall
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

3.  Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden.

Authors:  L Lindholm; M Rosén; L Weinehall; K Asplund
Journal:  J Epidemiol Community Health       Date:  1996-04       Impact factor: 3.710

4.  Cardiovascular risk during early adult life. Risk markers among participants in "Live for Life" health promotion programme in Sweden.

Authors:  L G Persson; K Lindström; H Lingfors; C Bengtsson; L Lissner
Journal:  J Epidemiol Community Health       Date:  1998-07       Impact factor: 3.710

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.